Galmed Pharmaceuticals
GLMD
GLMD
19 hedge funds and large institutions have $14.8M invested in Galmed Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
41% less capital invested
Capital invested by funds: $25M → $14.8M (-$10.2M)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$395K | |
| 2 | +$290K | |
| 3 | +$248K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$219K |
| 5 |
Morgan Stanley
New York
|
+$200K |
Top Sellers
| 1 | -$2.16M | |
| 2 | -$508K | |
| 3 | -$203K | |
| 4 |
CA
CapWealth Advisors
Franklin,
Tennessee
|
-$109K |
| 5 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
-$27K |